Topics

India Slams USTR Report As An Attack On Low-Cost Generics

03:11 EDT 30 Apr 2019 | SCRIP

India’s government and domestic drugmakers have condemned the USTR’s move to keep the country on a ‘priority watch list’ over...

      

Related Stories

 

Original Article: India Slams USTR Report As An Attack On Low-Cost Generics

NEXT ARTICLE

More From BioPortfolio on "India Slams USTR Report As An Attack On Low-Cost Generics"

Quick Search